• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3358 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) BMI reduction and chronic disease management: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suspended ceiling lifts: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) OnabotulinumtoxinA (Botox - Allergan Inc.) indication: chronic migraine
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Evaluation of measures related to the prevention of multiple falls in hospitalized elderly people]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine (Neupro - UCB Canada Inc.) indication: idiopathic Parkinson disease (early and advanced)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Anesthetic injections into the stellate ganglion for the treatment of hot flashes in women: a review of clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with surgically implanted devices: safety and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal oxygen saturation range for adults suffering from traumatic brain injury: a review of patient benefit, harms, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Junctional tourniquets for controlling hemorrhage from wounds in adults: a review of clinical effectiveness, cost-effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Electric shocks from conducted electric weapons: long-term clinical effects and guidelines for medical follow-up
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Antiemetics for adults experiencing opioid-induced nausea: a review of clinical and cost-effectiveness, benefits and harms, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Hearing protection fit testing systems: clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral intake in critical care patients: guidelines and recommendations
2014     Technology Assessment Unit of the McGill University Health Centre (MUHC) Islet transplantation in patients with Type 1 Diabetes Mellitus
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Positive expiratory pressure devices and incentive spirometers for the prevention of pneumonia: comparative clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic and non-pharmacologic treatments for alcohol withdrawal in the outpatient setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Capnography and/or oximetry monitoring of patients using patient-controlled intravenous opioids: clinical and cost-effectiveness, safety, and guidelines
2014     Technology Assessment Unit of the McGill University Health Centre (MUHC) Excimer laser atherectomy for uncrossable coronary lesions and improperly deployed coronary stents
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of chlorhexidine gluconate with alcohol for the prevention of peripheral intravenous device infections: a review of clinical and cost effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term sustained clinical remission after stopping first-line anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis: clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Dehumidifiers for reduction of humidity in operating rooms: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with a neurological impairment: diagnostic accuracy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) KRAS testing for metastatic colorectal cancer using therascreen KRAS RGQ PCR kit
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Naloxone prescribing: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aclidinium bromide (Tudorza Genuair - Almirall Canada Ltd.) indication: chronic obstructive pulmonary disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Developmental effects of in utero exposure to prescription drug abuse in infants and young children: harms
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) High-fidelity simulation training for health care professionals: cost effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Slow-release opioids for postoperative pain: clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriate use of hand-held wireless devices in healthcare settings: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Prolotherapy for the management of musculoskeletal pain: a review of the clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Bivalirudin infusion following angioplasty: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Brain electrical activity mapping for diagnosing psychiatric disorders: a review of the clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Rivaroxaban (Xarelto- Bayer Inc.) new Indication: pulmonary embolism
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aripiprazole for pregnant women: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Golimumab (Simponi - Janssen Inc.) new indication: ulcerative colitis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Neuro-linguistic programming for the treatment of adults with post-traumatic stress disorder, general anxiety disorder, or depression: a review of clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Nebulizers for the methacholine challenge test: diagnostic accuracy and guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Stereotactic ablative radiation therapy for the treatment of non-small cell lung cancer]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Locked units to limit access for dementia patients in long-term care facilities: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intra-aortic balloon pumps for cardiac conditions: guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Digital Breast Tomosynthesis]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcranial magnetic stimulation for the treatment of adults with PTSD, GAD, or depression: a review of clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Effectiveness and safety of single-use protective sheaths for flexible nasopharyngolaryngoscopes]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and risk stratification for diabetic foot ulcers: a review of clinical effectiveness, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of Fertil ProMD products in the treatment of infertility]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tocilizumab (Actemra - Hoffmann-La Roche Limited) new indication: polyarticular juvenile idiopathic arthritis
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Lung cancer: investigation, treatment and follow-up algorithms]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Equipment required for medication nebulization: safety and guidelines
2014     Health Quality Ontario (HQO) Point-of-care hemoglobin A1c testing: an evidence-based analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Fall prevention strategies for adults in outpatient programs: clinical evidence and guidelines
2014     Health Quality Ontario (HQO) Point-of-care hemoglobin A1c testing: a budget impact analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Mobile apps for improving health: clinical evidence
2014     Health Quality Ontario (HQO) Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: an evidence-based analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone (Inspra - Pfizer Canada Inc.) new indication: NYHA class II heart failure
2014     Health Quality Ontario (HQO) Point-of-care hemoglobin A1c testing: OHTAC recommendation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Direct acting antivirals for chronic hepatitis C genotype 1 in select populations: emerging evidence of clinical effectiveness and safety
2014     Health Quality Ontario (HQO) Hemoglobin A1c testing in diabetes: OHTAC recommendation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Closed intensive care units: clinical and cost-effectiveness, safety, and guidelines
2014     Health Quality Ontario (HQO) Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: OHTAC recommendation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) BMI reduction and chronic disease management: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suspended ceiling lifts: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Cleaning wipes for prevention of C. difficile infection in the hospital setting: clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal bacteriotherapy for adult patients with recurrent clostridium difficile infection: update of clinical, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Antibacterial sutures for wound closure after surgery: update on clinical effectiveness and guidelines for use
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Population-based colorectal cancer screening: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal photopheresis following bone marrow transplant: clinical effectiveness
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Portrait of the use of bisphosphonates and denosumab in patients aged 50 years or older with osteoporosis who are covered by the public prescription drug insurance program]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Post-surgical surveillance for surgical site infections: guidelines
2014     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of long-term left ventricular assist devices for advanced heart failure in Quebec from 2010 to 2012]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Oral nutrition intake for the prevention of falls in older adults: clinical effectiveness and guidelines
2014     Health Quality Ontario (HQO) Arthroscopic debridement of the knee: OHTAC recommendation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin supplementation for hospitalized adults: clinical evidence and guidelines
2014     Health Quality Ontario (HQO) End-of-life health care in Ontario: OHTAC recommendation
2014     Medical Advisory Secretariat (MAS) Multiple intravenous infusions
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tools assessing patient-reported outcome measures in cancer patients: accuracy and guidelines
2014     Health Quality Ontario (HQO) Arthroscopic debridement of the knee: an evidence update
2013     Health Quality Ontario (HQO) Effectiveness and safety of thrombolytics for the treatment of ischemic stroke: a rapid review
2013     Health Quality Ontario (HQO) Transient ischemic attack: where can patients receive optimal care? A rapid review
2013     Health Quality Ontario (HQO) Vasodilators for inhospital heart failure management: a rapid review
2013     Health Quality Ontario (HQO) Optimized timing of thrombolytic therapy for the treatment of stroke: a rapid review
2013     Health Quality Ontario (HQO) Early mobilization and ambulation in hospitalized heart failure patients:a rapid review
2013     Health Quality Ontario (HQO) Early mobilization and ambulation in hospitalized heart failure patients: a rapid review
2013     Health Quality Ontario (HQO) Coronary revascularization in ischemic heart failure patients: a rapid review
2013     Health Quality Ontario (HQO) The effectiveness of statins for primary prevention: a rapid review
2013     Health Quality Ontario (HQO) Effectiveness of increased intensity of rehabilitation in post-stroke patients: a rapid review
2013     Health Quality Ontario (HQO) Optimal onset-to-admission interval for inpatient stroke rehabilitation: a rapid review
2013     Health Quality Ontario (HQO) Optimal timing to begin an active rehabilitation program after a hip fracture: a rapid review
2013     Health Quality Ontario (HQO) Nerve blocks for pain management in patients with hip fractures: a rapid review